Off-patent pharmaceutical products manufactured by multiple generic drug companies. Sourced by hospitals, pharmacies, and wholesalers for cost-effective treatment options across various therapeutic areas. Distributed through B2B supply chains to support healthcare delivery in clinical and retail settings.